Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

ProQR Therapeutics N.V. buy kostojunior

Start price
€1.63
30.06.26 / 0%
Target price
-
30.06.27
Performance (%)
2.21%
Price
?
08:46
Summary
This prediction is currently active. The BUY prediction by kostojunior shows slight gains of 2.21%. This prediction currently runs until 30.06.27. The prediction end date can be changed by kostojunior at any time. This prediction was marked as speculative and is excluded from kostojunior's performance statistics.
Performance without dividends (%)
Name 1w 1m
ProQR Therapeutics N.V. 2.713% 2.713%
iShares Core DAX® 3.153% 1.504%
iShares Nasdaq 100 7.431% -1.584%
iShares Nikkei 225® 8.571% -4.324%
iShares S&P 500 4.578% 1.920%

According to kostojunior what are the pros and cons of ProQR Therapeutics N.V. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Normal challenges to pay loans and raise capital
Standard Investments for future growth
High dividend yield expected
Higher EBIT margin than peer group
Cons

Comments by kostojunior for this prediction

In the thread ProQR Therapeutics N.V. diskutieren

Buy ProQR Therapeutics N.V.